| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 07/20/2000 | WO2000041699A1 Use of estrogens and delta-gonadien-21-ol-3,20-diones |
| 07/20/2000 | WO2000041566A1 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 07/20/2000 | WO2000041545A2 Regulators of the pct or smoothened pathway, compositions and uses related thereto |
| 07/20/2000 | WO2000041531A2 Serine protease inhibitors |
| 07/20/2000 | WO2000041505A2 Anthranilic acid derivatives |
| 07/20/2000 | WO2000018418A3 Inhibition of erythrocyte sickling by n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester |
| 07/20/2000 | WO2000015250A3 Fibroblast inhibitor |
| 07/20/2000 | CA2370042A1 Regulators of the pct or smoothened pathway, compositions and uses related thereto |
| 07/20/2000 | CA2360268A1 Pre-conditioning against cell death |
| 07/20/2000 | CA2359798A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith |
| 07/20/2000 | CA2359479A1 Novel complex-forming proteins |
| 07/20/2000 | CA2359345A1 Methods for making proteins containing free cysteine residues |
| 07/20/2000 | CA2358684A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/20/2000 | CA2356934A1 Serine protease inhibitors |
| 07/20/2000 | CA2356776A1 Transcutaneous photodynamic treatment of targeted cells |
| 07/20/2000 | CA2356611A1 New use of melagatran |
| 07/20/2000 | CA2356440A1 New dialysis method |
| 07/20/2000 | CA2355792A1 New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 07/20/2000 | CA2349180A1 Anthranilic acid derivatives |
| 07/19/2000 | EP1019493A1 Generation of hematopoietic cells from multipotent neural stem cells |
| 07/19/2000 | EP1019406A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 07/19/2000 | EP1019396A1 Novel cycloalkyl substituted imidazoles |
| 07/19/2000 | EP1019394A1 PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS |
| 07/19/2000 | EP1019096A2 Bioresorbable compositions for implantable prostheses |
| 07/19/2000 | EP1019071A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 07/19/2000 | EP1019070A1 Bradykinin analogs as selective inhibitors of cell activation |
| 07/19/2000 | EP1019047A1 Antithrombotic agents |
| 07/19/2000 | EP1019045A1 Antithrombotic agents |
| 07/19/2000 | EP1018878A1 Novel indolecarboxamides, pharmaceutical compositions and methodsof inhibiting calpain |
| 07/19/2000 | EP1018877A1 Low molecular weight cell, bone marrow and immune stimulants |
| 07/19/2000 | EP0482208B1 Pyridazinone derivative |
| 07/19/2000 | CN1260720A Compositions useful as fibrin sealants |
| 07/19/2000 | CN1054531C Yunnan-Baiyao aerosol and preparing method |
| 07/18/2000 | US6090916 Protein with anticlotting activity; for treatment and prevention of thrombotic disorders |
| 07/18/2000 | US6090845 Hypotensive agent; vision defects |
| 07/18/2000 | US6090818 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them |
| 07/18/2000 | US6090803 Tricyclic vasopressin agonists |
| 07/18/2000 | US6090787 Antithrombotic agents |
| 07/18/2000 | US6090778 Neurturin and related growth factors |
| 07/18/2000 | US6090579 Human SDR2 cDNA clone |
| 07/18/2000 | US6090382 Human antibodies that bind human TNFα |
| 07/18/2000 | CA2175797C Human kunitz-type protease inhibitors |
| 07/18/2000 | CA2022183C Arylpyrazole derivatives as anti-platelet agents |
| 07/18/2000 | CA2004332C Inhibition of cell adhesion |
| 07/13/2000 | WO2000040733A1 Human cyclic nucleotide pdes |
| 07/13/2000 | WO2000040728A1 Nucleic acids and proteins corresponding to mutants of g-csf with granulopoietic activity |
| 07/13/2000 | WO2000040716A2 Soluble receptor br43x2 and methods of using them for therapy |
| 07/13/2000 | WO2000040583A2 Imidazo[4,5-c]-pyridine-4-on-derivatives |
| 07/13/2000 | WO2000040571A1 Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity) |
| 07/13/2000 | WO2000040548A1 Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 07/13/2000 | WO2000040278A1 Stent grafts with bioactive coatings |
| 07/13/2000 | WO2000040260A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 07/13/2000 | WO2000040243A1 Novel compounds |
| 07/13/2000 | WO2000040228A2 Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 07/13/2000 | WO2000025764A3 Compositions for the treatment and prevention of cardiovascular diseases |
| 07/13/2000 | WO2000024897B1 Cell surface molecule-induced macrophage activation |
| 07/13/2000 | WO2000019976A3 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them |
| 07/13/2000 | WO2000015800A3 Rac-like genes and methods of use |
| 07/13/2000 | DE19900743A1 Neue komplexbildende Proteine New complexing proteins |
| 07/13/2000 | DE19900471A1 Imidazo[4,5c]-pyridin-4-on-derivate Imidazo [4,5c] pyridin-4-one derivatives |
| 07/13/2000 | CA2753331A1 Soluble receptor br43x2 and methods of using |
| 07/13/2000 | CA2358578A1 Novel malonic acid derivatives, processes for their preparation, their use and pharmaceutical compositions containing them (inhibition of factor xa activity) |
| 07/13/2000 | CA2357811A1 Nucleic acids and proteins corresponding to mutants of g-csf with granulopoietic activity |
| 07/13/2000 | CA2357771A1 Imidazo[4,5-c]-pyridine-4-one derivatives |
| 07/13/2000 | CA2357146A1 Human cyclic nucleotide pdes |
| 07/13/2000 | CA2355873A1 Stent grafts with bioactive coatings |
| 07/13/2000 | CA2354194A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 07/12/2000 | EP1017678A1 1,5-diphenylpyrazole derivatives |
| 07/12/2000 | EP1017407A2 Useful properties of human lactoferrin and variants thereof |
| 07/12/2000 | EP1017405A1 Therapeutic hemoglobin composition having isotropically increased size |
| 07/12/2000 | EP1017393A1 Pyrazinone thrombin inhibitors |
| 07/12/2000 | EP1017385A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 |
| 07/12/2000 | EP1017383A1 Thrombin inhibitors |
| 07/12/2000 | EP1017378A1 Amide derivatives for the treatment of diseases mediated by cytokines |
| 07/12/2000 | EP0877734B1 Quinoline and quinazoline compounds useful in therapy |
| 07/12/2000 | EP0822932B1 Piperidine derivatives as diuretic |
| 07/12/2000 | CN1259942A Novel guanidine mimics as factor Xa inhibitors |
| 07/12/2000 | CN1259940A Crystalline roxifiban |
| 07/12/2000 | CN1259378A Oral liquid for restoring hemiplegia |
| 07/11/2000 | US6087487 Cdna molecule encoding a protein having nap domains and factor xa inhibitory activity; for in vitro diagnostic agents; in vivo therapy |
| 07/11/2000 | US6087479 Introducing into patient a medical device of which at least a portion includes a nitric oxide adduct which may be a sodium nitroprusside, a nitrosothiol, a nitrate, a nitrite or a nitrosated amino acid |
| 07/11/2000 | US6087381 Pyrazole derivatives as p38 kinase inhibitors |
| 07/11/2000 | US6087379 Cyclic amine derivatives |
| 07/11/2000 | US6087375 Methods of treating or preventing thromboses |
| 07/11/2000 | US6087368 Quinazolinone inhibitors of cGMP phosphodiesterase |
| 07/11/2000 | US6087167 Promoting neuron survival or neurite outgrowth by contacting neurons with an amount of an eck receptor binding protein of specific amino acid sequence |
| 07/11/2000 | US6087122 Polynucleotide sequence which codes a mammalian polypeptide synthetases; for diagnosis, evaluation, prevention, and treatment of physiological defects |
| 07/11/2000 | US6087087 Treatment of hemoglobin with nitric oxide |
| 07/11/2000 | US6086871 Prothrombin derivatives |
| 07/11/2000 | US6086573 Method of removing thrombosis in fistulae |
| 07/11/2000 | CA1341048C Method and compositions for making acsf and acsf antagonists |
| 07/06/2000 | WO2000039331A1 Single nucleotide polymorphism in a pyruvate dehydrogenase kinase isoenzyme 2 (pdk2) in humans |
| 07/06/2000 | WO2000039311A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 |
| 07/06/2000 | WO2000039290A2 Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid |
| 07/06/2000 | WO2000039285A2 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof |
| 07/06/2000 | WO2000039283A1 Use of cd40 engagement to alter t cell receptor usage |
| 07/06/2000 | WO2000039275A2 Multiple shear stress responsive elements (ssre) and methods of use thereof |
| 07/06/2000 | WO2000039249A1 Ume extract having medicinal effects and compositions containing the same |
| 07/06/2000 | WO2000039165A1 Serine protease inhibitor |
| 07/06/2000 | WO2000039136A2 Human brainiac-5 |